JPS5933212A - 麦角アルカロイド及びその水素化物並びにそれらの塩の安定溶液 - Google Patents
麦角アルカロイド及びその水素化物並びにそれらの塩の安定溶液Info
- Publication number
- JPS5933212A JPS5933212A JP58101046A JP10104683A JPS5933212A JP S5933212 A JPS5933212 A JP S5933212A JP 58101046 A JP58101046 A JP 58101046A JP 10104683 A JP10104683 A JP 10104683A JP S5933212 A JPS5933212 A JP S5933212A
- Authority
- JP
- Japan
- Prior art keywords
- solution
- dissolved
- alcohol
- polyhydric
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 5
- 150000004678 hydrides Chemical class 0.000 title claims description 4
- 229960003133 ergot alkaloid Drugs 0.000 title abstract description 5
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract 7
- 239000011877 solvent mixture Substances 0.000 claims abstract 4
- 239000000654 additive Substances 0.000 claims abstract 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000013772 propylene glycol Nutrition 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 7
- UJYGDMFEEDNVBF-UHFFFAOYSA-N Ergocorninine Natural products C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)C(C)C)C(C)C)C2)=C3C2=CNC3=C1 UJYGDMFEEDNVBF-UHFFFAOYSA-N 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- XQUUDUKVJKNJNP-OGGGUQDZSA-N ergocornine Chemical compound C([C@H]1N(C)C2)C([C]34)=CN=C4C=CC=C3C1=C[C@H]2C(=O)N[C@@]1(C(C)C)C(=O)N2[C@@H](C(C)C)C(=O)N3CCC[C@H]3[C@]2(O)O1 XQUUDUKVJKNJNP-OGGGUQDZSA-N 0.000 claims 2
- YDOTUXAWKBPQJW-UHFFFAOYSA-N ergocryptine Chemical compound C1=CC(C=2C(N(C)CC(C=2)C(=O)NC2(C(=O)N3C(C(N4CCCC4C3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=CNC3=C1 YDOTUXAWKBPQJW-UHFFFAOYSA-N 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 229940074391 gallic acid Drugs 0.000 claims 1
- 235000004515 gallic acid Nutrition 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 3
- 235000019441 ethanol Nutrition 0.000 abstract description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 abstract description 2
- 238000002309 gasification Methods 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 241000180579 Arca Species 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pregnancy & Childbirth (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE32271220 | 1982-07-20 | ||
| DE19823227122 DE3227122A1 (de) | 1982-07-20 | 1982-07-20 | Stabile loesungen von mutterkornalkaloiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5933212A true JPS5933212A (ja) | 1984-02-23 |
Family
ID=6168867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58101046A Pending JPS5933212A (ja) | 1982-07-20 | 1983-06-08 | 麦角アルカロイド及びその水素化物並びにそれらの塩の安定溶液 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0101879B2 (https=) |
| JP (1) | JPS5933212A (https=) |
| AT (1) | ATE39844T1 (https=) |
| DE (2) | DE3227122A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7171863B2 (en) | 2001-09-12 | 2007-02-06 | Olympus Corporation | Transfer unit and automatic analyzing apparatus having such transfer unit |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1200609B (it) * | 1985-04-04 | 1989-01-27 | Poli Ind Chimica Spa | Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano |
| AT381232B (de) * | 1985-05-13 | 1986-09-10 | Kwizda Fa F Johann | Verfahren zur herstellung stabiler fluessiger loesungen von ergolinderivaten |
| DE3710216A1 (de) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen |
| WO2000057851A2 (en) * | 1999-03-26 | 2000-10-05 | Pozen Inc. | High potency dihydroergotamine compositions |
| DE102007014947B4 (de) | 2007-03-23 | 2010-05-27 | Axxonis Pharma Ag | Stabilisierte wässrige Lösungen von Ergolinverbindungen |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5795907A (en) * | 1980-10-15 | 1982-06-15 | Rentschler Arzneimittel | Liquid medicine of ergot alkaloid |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD43402A (https=) * | ||||
| GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
| GB1494625A (en) * | 1974-02-04 | 1977-12-07 | Unilever Ltd | Pharmaceutical preparations |
| DK147775A (https=) * | 1974-04-16 | 1975-10-17 | Sandoz Ag | |
| DE2518677A1 (de) * | 1974-05-06 | 1975-11-20 | Sandoz Ag | Neue pharmazeutische zubereitungen |
| FI761461A7 (https=) * | 1975-05-31 | 1976-12-01 | Sandoz Ag | |
| DE2735587A1 (de) * | 1977-08-06 | 1979-02-15 | Sandoz Ag | Stabile loesungen und verfahren zu deren herstellung |
| DE2555481C3 (de) * | 1975-12-10 | 1985-10-03 | Sandoz-Patent-GmbH, 7850 Lörrach | Herstellung stabiler Tropflösungen von hydrierten Ergotalkaloiden |
| DE2945636A1 (de) * | 1979-11-12 | 1981-05-21 | Sandoz-Patent-GmbH, 7850 Lörrach | Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung |
| BE880542A (fr) * | 1979-12-11 | 1980-06-11 | Christiaens Sa A | Solutions aqueuses stables d'alcaloides de l'ergot de seigle |
-
1982
- 1982-07-20 DE DE19823227122 patent/DE3227122A1/de active Granted
-
1983
- 1983-06-08 JP JP58101046A patent/JPS5933212A/ja active Pending
- 1983-07-18 DE DE8383107034T patent/DE3378892D1/de not_active Expired
- 1983-07-18 AT AT83107034T patent/ATE39844T1/de not_active IP Right Cessation
- 1983-07-18 EP EP83107034A patent/EP0101879B2/de not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5795907A (en) * | 1980-10-15 | 1982-06-15 | Rentschler Arzneimittel | Liquid medicine of ergot alkaloid |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7171863B2 (en) | 2001-09-12 | 2007-02-06 | Olympus Corporation | Transfer unit and automatic analyzing apparatus having such transfer unit |
Also Published As
| Publication number | Publication date |
|---|---|
| DE3227122C2 (https=) | 1988-07-14 |
| EP0101879A2 (de) | 1984-03-07 |
| DE3378892D1 (en) | 1989-02-16 |
| EP0101879A3 (en) | 1985-04-03 |
| EP0101879B1 (de) | 1989-01-11 |
| EP0101879B2 (de) | 1993-11-10 |
| ATE39844T1 (de) | 1989-01-15 |
| DE3227122A1 (de) | 1984-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2096091T7 (es) | Nuevas composiciones a base de derivados de la clase de los taxanos. | |
| JP2005515202A (ja) | プラチナ誘導体の薬学的調合物 | |
| JPH11506463A (ja) | 親脂性に富んだカンプトテシン誘導体治療薬 | |
| JP4302990B2 (ja) | 安定かつ高濃度であるピラゾロン誘導体を含む注射剤 | |
| JPH07505628A (ja) | 静脈注射用のラパマイシン製剤 | |
| JPS5933212A (ja) | 麦角アルカロイド及びその水素化物並びにそれらの塩の安定溶液 | |
| FI87993B (fi) | Foerfarande foer framstaellning av alkaliska injektionsloesningar av torasemid innehaollande vatten, som aer faerdiga foer injicering | |
| JP4543679B2 (ja) | 唯一の共同溶剤としてプロピレングリコールを含んでいる使用準備ができているパラセタモール注射溶液 | |
| JPH04275222A (ja) | 安定性を強化したピロキシカム溶液、およびその製造方法 | |
| NZ201046A (en) | Soft elastic gelatine capsule dosage forms containing solution of ergot alkaloid in solvent unreactive with capsule shell | |
| JP4535234B2 (ja) | 腸管洗浄製剤 | |
| FR2863891A1 (fr) | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation | |
| US4402949A (en) | Stable solutions of hydrogenated ergotalkaloids | |
| JP2012214509A (ja) | カンプトテシン医薬処方物およびその製法 | |
| CA1069438A (en) | Stable solutions and processes for their preparation | |
| JPH0283318A (ja) | 安定な点眼剤 | |
| JPS6245524A (ja) | ナトリウムフエニトイン水性製剤 | |
| RU2242231C2 (ru) | Парентеральная композиция для лечения эпилепсии | |
| JPH0725735A (ja) | 含嗽剤 | |
| JP2001163776A (ja) | 安定化された液剤 | |
| WO2020011753A1 (en) | Compositions for therapeutic uses containing 5-htp and carbidopa | |
| HU179989B (en) | Process for preparing pharmacological compositions containing r-/+/-1-/1-phenyl-ethyl/-1h-imidazol-5-carboxylic acid ethyl ester for intravenous administration | |
| JP2571390B2 (ja) | 獣医用治療剤 | |
| US5034397A (en) | Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone | |
| JPS61180771A (ja) | 安定な抗バクテリア剤水溶液 |